Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 June 2024 | Story Edzani Nephalela | Photo Supplied
Dr Nomalungelo Ngubane
Dr Nomalungelo Ngubane, the Director of the Academy for Multilingualism, is at the forefront of this initiative, championing diversity and inclusiveness for all stakeholders at the University of the Free State.

Diversity in higher education institutions enriches the learning environment, fostering a culture of inclusion and mutual respect. It broadens perspectives, encourages critical thinking, and prepares students for a global workforce by supporting equitable access to opportunities and enhancing all students' personal growth and academic excellence.

The University of the Free State (UFS) has marked a significant milestone in its commitment to linguistic diversity with the official translation of its Language Policy into three additional languages: Sesotho, Afrikaans, and isiZulu. Previously only available in English, the translation of the policy – approved by the University Council in November 2023 – into these languages reflects the university's dedication to inclusivity and recognition of its diverse community.

The collaboration between the Academy for Multilingualism and the Institutional Regulatory Code was instrumental in a groundbreaking initiative: making the Language Policy accessible to speakers of African languages. Spearheaded by the Academy for Multilingualism, this endeavour involved a thorough translation, formatting, and proofreading process.

Dr Nomalungelo Ngubane, Director of the Academy for Multilingualism, emphasised that the availability of the Language Policy in multiple languages is not merely symbolic, but underscores the UFS' values of respect, human dignity, and social justice, as outlined in its Vision130. “This initiative aligns with the university's overarching goal of fostering an environment where all languages are valued and respected. We also hope that the Language Policy will not just be written in different languages but will strengthen the implementation of the policy in various domains of the university to achieve its objectives.

She further explains that the translation project is expected to have far-reaching impacts on how policies are communicated and understood within the university, because it enhances the ability of students, staff, and stakeholders to participate more fully in university life, contributing to a more cohesive and integrated community.

This initiative is a testament to the UFS' commitment to embracing and celebrating linguistic diversity as a fundamental aspect of its identity and operations.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept